David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at thr Gustave Roussy, shared a post on LinkedIn:
“A moment of exchange this morning with my Chinese colleagues on EGFR-mutated NSCLC patients.
Thank you for the invitation and the quality of the discussions! Clinical research continues for our patients with many new molecules on the way, I hope…”
More posts featuring David Planchard on OncoDaily.